Lv31
308 积分 2025-03-13 加入
The role of JAK/STAT signaling pathway and its inhibitors in diseases
1个月前
已完结
Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA Perspective
1个月前
已完结
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors’ failure: a review of current and investigational treatment for HR+/Her2- breast cancer
4个月前
已完结
Radiolabeled Absorption, Distribution, Metabolism, and Excretion Studies in Drug Development: Why, When, and How?
5个月前
已完结
Mass Balance Studies in Animals and Humans
5个月前
已完结
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
5个月前
已完结
Sacituzumab govitecan for hormone receptor–positive HER2-negative advanced breast cancer
5个月前
已完结
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors’ failure: a review of current and investigational treatment for HR+/Her2- breast cancer
5个月前
已完结
Tyrosine kinase 2 inhibitors in autoimmune diseases
6个月前
已完结
皖公网安备34019202002308
